We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
-10.27%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.85B
AUM Growth
+$215M
Cap. Flow
+$467M
Cap. Flow %
25.25%
Top 10 Hldgs %
43.87%
Holding
2,269
New
792
Increased
360
Reduced
332
Closed
760

Sector Composition

Rank Sector Weight
1 Financials 5.22%
2 Technology 4.19%
3 Energy 3.73%
4 Healthcare 3.61%
5 Consumer Discretionary 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SABA
1176
Saba Capital Income & Opportunities Fund II
SABA
$222M
$83K ﹤0.01%
+6,904
New +$84.4K
AXAS
1177
DELISTED
Abraxas Petroleum Corp
AXAS
$83K ﹤0.01%
+3,805
New +$133K
JQC icon
1178
Nuveen Credit Strategies Income Fund
JQC
$714M
$82K ﹤0.01%
+11,039
New +$84.5K
SVRA icon
1179
Savara
SVRA
$1.15B
$82K ﹤0.01%
+10,801
New +$97.2K
XFOR icon
1180
X4 Pharmaceuticals
XFOR
$424M
$82K ﹤0.01%
196
+69
+54% +$26.3K
TRVN
1181
DELISTED
Trevena, Inc.
TRVN
$82K ﹤0.01%
+305
New +$172K
CHS
1182
DELISTED
Chicos FAS, Inc.
CHS
$82K ﹤0.01%
+14,634
New +$102K
HTGM
1183
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$82K ﹤0.01%
179
-58
-24% -$36K
BGFV
1184
DELISTED
Big 5 Sporting Goods
BGFV
$81K ﹤0.01%
+31,102
New +$124K
FRO icon
1185
Frontline
FRO
$8.62B
$81K ﹤0.01%
+14,644
New +$95.7K
IAF
1186
abrdn Australia Equity Fund
IAF
$127M
$81K ﹤0.01%
+5,700
New +$89.3K
RKDA icon
1187
Arcadia Biosciences
RKDA
$1.51M
$81K ﹤0.01%
642
+24
+4% +$4.03K
FPL
1188
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$81K ﹤0.01%
+10,790
New +$92.5K
XBIT icon
1189
XBiotech
XBIT
$71.6M
$80K ﹤0.01%
+15,682
New +$64.3K
XENE icon
1190
Xenon Pharmaceuticals
XENE
$6.16B
$80K ﹤0.01%
+12,696
New +$113K
PER
1191
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$79K ﹤0.01%
41,851
-15,025
-26% -$34.8K
RMBS icon
1192
Rambus
RMBS
$10.9B
$78K ﹤0.01%
10,138
-6,750
-40% -$58.7K
AAIC
1193
DELISTED
Arlington Asset Investment Corp.
AAIC
$78K ﹤0.01%
+10,725
New +$90.1K
BLCM
1194
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$78K ﹤0.01%
2,672
-1,195
-31% -$53K
CVE icon
1195
Cenovus Energy
CVE
$55.3B
$77K ﹤0.01%
10,946
-24,511
-69% -$202K
JEMD
1196
DELISTED
Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share
JEMD
$77K ﹤0.01%
+10,075
New +$77.9K
SNR
1197
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$77K ﹤0.01%
+18,664
New +$98.3K
FRED
1198
DELISTED
Fred's Inc
FRED
$77K ﹤0.01%
+40,535
New +$105K
BNED icon
1199
Barnes & Noble Education
BNED
$427M
$76K ﹤0.01%
+191
New +$106K
SNDA icon
1200
Sonida Senior Living
SNDA
$1.86B
$76K ﹤0.01%
+744
New +$92.8K

Similar funds

Virtu Financial's Q4 2018 Portfolio in Review

As of Q4 2018, Virtu Financial held 2,269 positions worth $1.85B, up 13% from $1.63B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Virtu Financial deployed $467M of net new capital in Q4 2018, opening 792 new positions and adding to 360 existing holdings. Its largest new stake was United States Oil Fund: 167,759 shares worth $13M.

By sector, the portfolio is most concentrated in Financials at 5.2% of assets, down from 9.5% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $23.8M trimmed.

  • Virtu Financial's largest Q4 2018 buy was United States Oil Fund: 167,759 shares worth $13M.
  • Virtu Financial added most to Vanguard S&P 500 ETF in Q4 2018, an estimated $38.8M increase.
  • Virtu Financial's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $23.8M.
  • Virtu Financial fully exited iShares Core S&P 500 ETF in Q4 2018, selling an estimated $44.4M.
  • Virtu Financial's ten largest holdings make up 44% of its $1.85B portfolio in Q4 2018.
  • Virtu Financial opened 792 new positions and closed 760 in Q4 2018.
  • Virtu Financial's portfolio value rose 13% quarter-over-quarter to $1.85B.

Based on Virtu Financial's 13F filing for Q4 2018, filed 16 Jan 2019.